Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Glamour Shots once ruled the mall. I went to one of the last ones standing. - 2Heartfelt Objections to Visit with Your Adored One
- 3UN mission says no evidence Hezbollah rearming in southern Lebanon
- 4Make your choice for the music application with the most amicable connection point!
- 5Deadly Switzerland ski resort fire was likely started by sparklers attached to champagne bottles, officials say
- Interstellar comet 3I/ATLAS to pass closest to Earth on Friday
- Change Your Home into an Exercise center with These Famous Wellness Gadgets
- Iran-backed militias reassert power in Iraq, proving the Islamic axis is still standing
- This Flashy Old-School Design Trend From Italy Still Has A Place In Modern Kitchens
- How food assistance programs can feed families and nourish their dignity
- Rick Steves' Newest Guidebook Is A Fresh Perspective On Italy Spilling The Country's Secrets
- Figure out How to Function Successfully with Your Auto Collision Legal advisor for the Best Result
- Why the chemtrail conspiracy theory lingers and grows – and why Tucker Carlson is talking about it
- Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'
